Categories: Healthcare

MicroRNA Global Market Size, Insights, Outlook, and Overview by 2024-2033

3D render of a medical background with DNA strands

Overview and Scope

MicroRNAs are small, non-coding RNA molecules, typically about 20-22 nucleotides in length, used to regulate gene expression. They function by binding to complementary sequences on messenger RNA (mRNA) molecules, usually resulting in gene silencing through translational repression or target degradation.

Sizing and Forecast

The microRNA market size has grown rapidly in recent years. It will grow from $1.12 billion in 2023 to $1.33 billion in 2024 at a compound annual growth rate (CAGR) of 18.3%. The growth in the historic period can be attributed to discovery of microRNAs, RNA interference (RNAi), genome sequencing projects, computational biology and bioinformatics, and extracellular vehicles (EVs) research.

The microRNA market size is expected to see rapid growth in the next few years. It will grow to $2.63 billion in 2028 at a compound annual growth rate (CAGR) of 18.6%. The growth in the forecast period can be attributed to clinical translation, regulatory networks and systems biology, microRNA-based therapeutics, therapeutic potential, and biomarker discovery. Major trends in the forecast period include technological advances, bioinformatics and data analysis, cross-species conservation, microbiome interactions, and functional mechanisms.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/microrna-global-market-report

Segmentation & Regional Insights

The microRNA market covered in this report is segmented –

1) By Products: Instruments, Consumables
2) By Assay Type: Immunoassay, Next Generation Sequencing, miRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays
3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications
4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations

North America was the largest region in the microRNA market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp

Major Driver Impacting Market Growth

The increasing number of cancer cases is expected to propel the growth of the microRNA market going forward. Cancer refers to a complex disease characterized by uncontrolled cell growth and proliferation, often leading to the formation of malignant tumors that can invade surrounding tissues and spread to distant organs, posing significant health risks. The increasing number of cancer cases is due to various factors, including aging populations, lifestyle choices such as smoking and poor diet, environmental pollutants, and improved detection methods leading to earlier diagnosis. MicroRNA is combined with traditional cancer therapies to enhance drug sensitivity and improve outcomes. Beyond treatment, miRNAs serve as diagnostic and prognostic biomarkers, helping to identify cancer types, predict disease progression, and monitor treatment responses. For instance, in May 2024, according to the National Cancer Institute, a US-based government agency, around 20 million new cases and 9.7 million cancer-related deaths were recorded annually in 2022, and predictions indicate that by 2040, there would be 15.3 million deaths and 29.9 million new cases per year. Therefore, the increasing number of cancer cases is driving the growth of the microRNA market.

Key Industry Players

Major companies operating in the MicroRNA market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc, Kaneka Corporation, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Biodynamics Laboratory Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Biogenex Laboratories, Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc., Synlogic Inc, Sistemic Scotland Limited

The microrna market report table of contents includes:

1. Executive Summary

2. MicroRNA Market Characteristics

3. MicroRNA Market Trends And Strategies

4. MicroRNA Market – Macro Economic Scenario

5. Global MicroRNA Market Size and Growth

…

32. Global MicroRNA Market Competitive Benchmarking

33. Global MicroRNA Market Competitive Dashboard

34. Key Mergers And Acquisitions In The MicroRNA Market

35. MicroRNA Market Future Outlook and Potential Analysis

36. Appendix